entrepreneur with experience in biotechnology, healthcare, and emerging technologies. Known for founding and leading companies that turn cutting-edge ideas
.@ArgentBioPharma has filed a provisional patent application with the United States Patent and Trademark Office for its novel NanoBodies platform.
#ASX#health $RGT
https://t.co/pb1K8ybK7q
.@ArgentBioPharma has filed a provisional patent application with the United States Patent and Trademark Office for its novel NanoBodies platform.
#ASX#health $RGT
https://t.co/pb1K8ybK7q
.@ArgentBioPharma has announced its largest single commercial shipment in the company’s history: 1000 units of its flagship cannabinoid formulation CannEpil to Ireland.
#ASX#health $RGT
https://t.co/t5giha3IMY
Case report shows clinical benefits for Argent BioPharma's CannEpil in a paediatric patient with Lennox-Gastaut Syndrome.
#ASX#health $RGT @ArgentBioPharma
https://t.co/YekNSkQIAX
🚨 Star Wars Are Here — In Real Life 🚨
Earlier today, the Israeli Air Force deployed its cutting-edge “Barak” air defense system to intercept an enemy UAV that breached Israeli airspace.
IDF Spokesperson:
“The ‘Barak’ system, first used in the Air Force’s air defense system, intercepted an unmanned aerial vehicle… developed in Israel to protect against aerial threats.”
This isn’t science fiction — it’s real-time defense tech, designed and built in Israel, guarding our skies.
As the region grows more complex, Israel’s Air Force remains firmly committed to maintaining air superiority and neutralizing threats with next-gen precision.
#IDF #AirForce #IsraelDefense #BarakSystem #StarWarsIsNow #AerialSuperiority
💡 Dementia Misconceptions
The 2024 World Alzheimer Report reveals over 58% of people believe dementia is caused by an unhealthy lifestyle. In some countries, 84.1% of those with dementia think it's just a natural part of aging.
Read the report :
https://t.co/qGnEIAQZNM
📦 First shipment of CogniCann has officially reached Germany!
This marks a meaningful step forward in expanding access to cannabinoid-based therapies. We’re proud to see progress that brings innovation closer to those who need it.
#CogniCann#CannabinoidTherapy#Germany#Pharma
CogniCann® is an 𝗜𝗻𝘃𝗲𝘀𝘁𝗶𝗴𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗠𝗲𝗱𝗶𝗰𝗶𝗻𝗮𝗹 𝗽𝗿𝗼𝗱𝘂𝗰𝘁, potentially indicated for symptoms associated with 𝗗𝗲𝗺𝗲𝗻𝘁𝗶𝗮 𝗮𝗻𝗱 𝗔𝗹𝘇𝗵𝗲𝗶𝗺𝗲𝗿’𝘀.
📺 Learn more about CogniCann® and our work:
https://t.co/rAOnWUgDQI
#MedicalInnovation
The last quarter has been a memorable one for
@MGC_Pharma, with projects coming to fruition as a global business. The strides we’ve made in advancing CimetrA™ and ArtemiC™ to the global stage is a milestone we are particularly proud of.
Another milestone announcement for @MGC_Pharma as we approach the end of the year. This study could have a hugely positive impact for hundreds of millions of Long-Covid sufferers around the world.
I recently spoke to @londondailypost about the efforts made by @MGC_Pharma to bring plant-derived medicines to the public and how clinical trials can help reach a broader audience, helping more people.
Read the article below:
https://t.co/3fFNqUKjUT